ALT-836

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameALT-836
Drug Alias NameSunolcH-36TNX-832cH-36ALT-836
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Chimeric monoclonal antibody
Mechanisms of ActionTissue factor inhibitors
TargetsTissue factor
Therapy Area/IndicationsSolid tumoursRespiratory Distress Syndrome, AdultAcute Lung Injury +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesSunol Molecular Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTanox IncGenentech IncAltor Bioscience Corp
Active IndicationsN/A
Inactive IndicationsSolid tumoursRespiratory Distress Syndrome, AdultAcute Lung Injury +[5] 

Other Information

ATC CodeN/A
Related LinksN/A